PHP
ETNB

Parkman Healthcare Partners’s 89bio ETNB Stock Holding History

Parkman Healthcare Partners’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-179,899
Closed -$2.09M – 97
2024
Q1 		$2.09M Sell
179,899
-39,549
-18% -$438K 0.26% 85
2023
Q4 		$2.45M Sell
219,448
-144,105
-40% -$1.32M 0.35% 70
2023
Q3 		$5.61M Buy
363,553
+14,678
+4% +$246K 1.03% 32
2023
Q2 		$6.61M Buy
348,875
+101,919
+41% +$1.79M 1.15% 27
2023
Q1 		$3.76M Sell
246,956
-85,924
-26% -$1.12M 0.82% 43
2022
Q4 		$4.24M Buy
332,880
+107,880
+48% +$971K 1.13% 36
2022
Q3 		$1.3M Buy
+225,000
New +$989K 0.37% 68
2022
Q1 		– Sell
-152,098
Closed -$1.99M – 83
2021
Q4 		$1.99M Buy
152,098
+6,250
+4% +$98.8K 0.44% 58
2021
Q3 		$2.86M Buy
145,848
+10,000
+7% +$183K 0.72% 42
2021
Q2 		$2.54M Buy
135,848
+33,685
+33% +$752K 0.56% 50
2021
Q1 		$2.42M Buy
102,163
+5,490
+6% +$127K 0.56% 49
2020
Q4 		$2.36M Sell
96,673
-13,327
-12% -$341K 0.6% 55
2020
Q3 		$2.82M Buy
+110,000
New +$3.49M 0.75% 48

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Parkman Healthcare Partners's ETNB Position: Q2 2024 in Review

Parkman Healthcare Partners sold out of 89bio (ETNB) in Q2 2024, closing a stake of 179,899 shares — an estimated $2.09M sold.

Parkman Healthcare Partners first reported a position in ETNB in Q3 2020 and held it in 13 quarters. The position peaked at $6.61M in Q2 2023. 145 funds tracked by Wall St. Rank hold ETNB as of Q2 2024.

  • Parkman Healthcare Partners reported no remaining 89bio position as of Q2 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 179,899 89bio shares in Q2 2024, an estimated $2.09M.
  • Parkman Healthcare Partners first reported a position in 89bio in Q3 2020 and held it in 13 quarters.
  • Parkman Healthcare Partners's 89bio position peaked at $6.61M in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 89bio as of Q2 2024.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.